Webinar

Quote






anonymous said:
i dont know how long you have been with Iroko but the marketing team including the SVP and Executive Director of Zorvolex have spent majority of their time working with reps in the territories since launch and all of 2014. They have also conducted advisory board meetings in various regions and local areas meeting over 500 physicians. They have also been very hands on visiting majority of the managed care organization personnel. They also have systematically collected customer feedback through organized market research in both qualitative and quantitative manner periodically so that they understand the progress of the messages with customers, their questions and what the best way to answer them. The analytics done with the data is one of the best in the industry.

Regarding your comment on the managed care organizations and the mergers, if you had the perspective of following the industry over the past 20 years or so, what you will see is the various stakeholders make strategic moves and neutralize the others advantage. It is really fascinating not only to watch but be a part of the process. That is what is fun. In the early 90s when the PBMs like Medco were beginning to emerge, there was similar cries of the sky falling down. However, what you see is how the various stakeholders like the pharma, physicians, pharmacies all respond to neutralize the others' advantage. What you have stated are signficant strategic moves by the payers. However pls. do not underestimate the role played by pharma. Payers cannot exist without pharma. Despite all these posturing, what the payers want is to use pharmaceuticals to reduce the use of procedures and hospitalizations. You will see Pharma and physcian groups make strategic adjustments. and regarding your jobs, despite all the hue and cry, if you ask most top executives in Pharma, personal selling is the most effective communication media in this industry - none of the others including digital have shown to be anywhere close. So I wouldnt worry. It was just that in the late 90's and early 2000s, excess capacity was added - so when the R&D productivity for pharma in terms of new drugs began to become lean, that excess capacity was shed.
Click to expand...
 






anonymous said:
i dont know how long you have been with Iroko but the marketing team including the SVP and Executive Director of Zorvolex have spent majority of their time working with reps in the territories since launch and all of 2014. They have also conducted advisory board meetings in various regions and local areas meeting over 500 physicians. They have also been very hands on visiting majority of the managed care organization personnel. They also have systematically collected customer feedback through organized market research in both qualitative and quantitative manner periodically so that they understand the progress of the messages with customers, their questions and what the best way to answer them. The analytics done with the data is one of the best in the industry.

Regarding your comment on the managed care organizations and the mergers, if you had the perspective of following the industry over the past 20 years or so, what you will see is the various stakeholders make strategic moves and neutralize the others advantage. It is really fascinating not only to watch but be a part of the process. That is what is fun. In the early 90s when the PBMs like Medco were beginning to emerge, there was similar cries of the sky falling down. However, what you see is how the various stakeholders like the pharma, physicians, pharmacies all respond to neutralize the others' advantage. What you have stated are signficant strategic moves by the payers. However pls. do not underestimate the role played by pharma. Payers cannot exist without pharma. Despite all these posturing, what the payers want is to use pharmaceuticals to reduce the use of procedures and hospitalizations. You will see Pharma and physcian groups make strategic adjustments. and regarding your jobs, despite all the hue and cry, if you ask most top executives in Pharma, personal selling is the most effective communication media in this industry - none of the others including digital have shown to be anywhere close. So I wouldnt worry. It was just that in the late 90's and early 2000s, excess capacity was added - so when the R&D productivity for pharma in terms of new drugs began to become lean, that excess capacity was shed.
Click to expand...
 






advisory board meetings?! You dummies don't get it. Most docs will tell you what you want to here at those things, just give them their cash for showing up. But what do I know? The millions you numb nuts spent on stupid marketing research so far worked......right?
 


















Top Bottom
Back
Quote